# Sino-Singapore Capital

> Sino-Singapore Capital is a VC fund in Dongcheng backing Manufacturing and Medical. See 21 investments, check sizes, portfolio. Updated Aug 2026.

- Type: VC Fund
- Location: Dongcheng, China
- Total investments: 21
- Last investment: Sep 2025
- Lead investor: 5%
- Last updated: Aug 2026
- Website: http://www.zxrc.com.cn/

Sino-Singapore Capital is a private equity firm.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $1.6M–$15M |
| Series A | $21M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Manufacturing | 6 | 29% |
| Medical | 4 | 19% |
| Electronics | 4 | 19% |
| Biotechnology | 4 | 19% |
| Pharmaceutical | 4 | 19% |

31 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 7 | 33% |
| Series A | 4 | 19% |
| Series B | 3 | 14% |
| Angel | 2 | 10% |
| Venture - Series Unknown | 2 | 10% |

8 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| UniX AI | UniX AI possesses advanced research and development capabilities in the domain of embodied intelligent robotics. The team comprises specialists from various disciplines, including structural engineering, electronics, algorithms, and deep learning. This technology company focuses on enhancing the robot's ability to generalize in intricatescenarios. |  | Angel | Sep 29, 2025 | https://www.unix-group.ai/ |
| Tiejin Technology | Tiejin Technology is a humanoid robotics company that provides research and development related to micro and ultra-micro bearings. | $27.9M | Private Equity | Jun 30, 2025 | http://www.stt-bearing.com |
| Bennett Optical Technology | Bennet Optical Technology is a high-technology company that designs, manufactures, and supports liquid crystal on silicon (LCoS) optical products and systems. |  | Series A | Dec 12, 2024 | http://www.bilightech.com |
| XellSmart | Xellsmart develops stem cell treatment solutions for a variety of degenerative diseases for which there are now no clinical treatments. Xellsmart is located in Minhang District, Shanghai, China. | $14M | Series B | Oct 21, 2024 | http://www.xellsmart.com |
| Zhixing Optoelectronics | Zhixing Optoelectronics is a manufacturer of optoelectronic devices that focuses on intelligent driving vehicle imaging modules. It is a wholly-owned subsidiary of LianChuang Electronic. | $14.2M | Venture - Series Unknown | Sep 23, 2024 |  |
| Shenzhen Jinminjiang Intelligent Equipment Co. | Shenzhen Jinminjiang Intelligent Equipment Co. manufactures and sells motor production and testing equipment for industrial plants. |  | Series B | Feb 23, 2024 | https://www.gimech.com |
| AI-LINK | AI-LINK is a digital infrastructure provider focused on industrial sites. | $21.1M | Series A | Feb 01, 2024 | https://en.ailinking.com |
| Secretech | Secretech is a R&D-driven biotechnology company.Secretechis creates biomarkers and cellular exosomes and is dedicated to the discovery and development of novel biomarkers and cellular exosomes. |  | Angel | Jan 19, 2024 | https://www.secretech.com |
| Bingjing Smart | Bingjing Smart is a cardiovascular interventional imaging company. It is an acoustics-based startup that uses imaging as a form of communication and is aiming for the digital medical revolution. It creates specialist digital interventional imaging products for heart and vascular illnesses. It helps in advancement of digital cardiovascularinterventional imaging, leveraging digital to empower the entire process of cardiovascular disease diagnosis and treatment. |  | Seed | Jan 02, 2024 |  |
| Main Function Intelligence | Main Function Intelligence is a provider of unmanned mining transportation systems that focus on intelligent mining and wire-controlled wide-body vehicles. |  | Series A | Oct 09, 2023 | http://www.mainfunc.cn |

10 of 21 investments shown.

## Co-investors
- [Frees Fund](https://shizune.co/investors/profile/freesfund) — VC Fund, 3 deals together
- [Oriza Holdings](https://shizune.co/investors/profile/oriza-holdings) — VC Fund, 3 deals together
- [BioVenture](https://shizune.co/investors/profile/bioventure) — VC Fund, 2 deals together
- [CD Capital](https://shizune.co/investors/profile/cd-capital) — VC Fund, 2 deals together
- [China Singapore Suzhou Industrial Park Ventures](https://shizune.co/investors/profile/china-singapore-suzhou-industrial-park-ventures-co) — VC Fund, 2 deals together
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund, 2 deals together

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [East Ventures](https://shizune.co/investors/profile/east-ventures) — VC Fund
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund

## Featured in investor lists
- [Life Science VC Funds in Asia](https://shizune.co/investors/life-science-vc-funds-asia)
- [Life Science Investors in China](https://shizune.co/investors/life-science-investors-china)
- [Life Science VC Funds in China](https://shizune.co/investors/life-science-vc-funds-china)
- [Infrastructure Investors in Asia](https://shizune.co/investors/infrastructure-investors-asia)
- [Life Science Investors in Asia](https://shizune.co/investors/life-science-investors-asia)

## FAQ

### What does Sino-Singapore Capital invest in?

Sino-Singapore Capital invests primarily in Manufacturing, Medical and Electronics startups, most often at Seed and Series A stage. Most of the 21 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Sino-Singapore Capital's check size?

Sino-Singapore Capital typically joins rounds of $1.6M–$15M at Seed and $21M–$30M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Sino-Singapore Capital participates in.

### When did Sino-Singapore Capital last invest?

The most recent investment recorded for Sino-Singapore Capital closed in Sep 2025. Shizune tracks 21 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co